AstraZeneca axes 3,000 jobs worldwide
685161
Anglo-Swedish pharmaceuticals giant AstraZeneca said it would axe almost five percent of its workforce over the next three years amid a growing threat from generic drugs makers.
45410
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down as much as 9.2 percent.
417984
SHANGHAI, China Sept. 15, 2004 - With AIDS making disastrous new inroads in the Asian-Pacific region, World Health Organization experts are evaluating progress toward providing anti-AIDS drugs to 3 million
583059
LONDON, October 6  - AstraZeneca (AZN.ISE) has delayed the regulatory approval filing target for its diabetes drug, Galida, from 2006 to 2007, while admitting that its anti-blood clotting drug, Exanta, was unlikely to receive the US
463333
AstraZeneca faced its third major setback in as many months yesterday after clinical trials dashed expectations that its lung cancer drug Iressa would develop into a blockbuster product that would dominate treatment around the world.
321610
ASTRAZENECA effectively admitted yesterday that its drug development programme was in disarray, as the Anglo-Swedish giant appointed a new director to review the operation.
22568
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down as much as 9.2 percent.
346497
An FDA review of AstraZeneca Plc&#39;s (AZN.L: Quote, Profile, Research) (AZN.N: Quote, Profile, Research) Exanta questioned the experimental drug&#39;s
752652
AstraZeneca is spending 75 million pounds to take a 20 percent stake in Cambridge Antibody Technology and boost its position in one of the fastest-growing fields of drug research.
639647
Troubled Anglo-Swedish drugs giant AstraZeneca reported a 15.7-percent rise in profits for 2004, despite controversy over key products and amid speculation about the future of its chief executive.
613239
Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 billion, the drug maker said Thursday.
151661
EuropeÂs biggest drug maker, said that it would pay $3.1 billion to settle a tax dispute with the United States government.
637256
European shares clung to 2-1/2 year  highs on Wednesday after U.S. blue chips hit their best level  in 3-1/2 years, with drugmaker AstraZeneca starring after Japan  gave the green light to a key drug.
390715
AstraZeneca Plc. said on Wednesday a new  study in Japan showed a higher rate of a potentially fatal side  effect in patients taking its lung cancer pill Iressa than that  demonstrated in an earlier analysis.
290127
Sainsbury's is set to create 3,000 jobs as it looks to improve services at its stores, newspapers report.
460971
Will AstraZeneca become the latest casualty in the drug safety debate?
348260
PARIS  - The newly formed pharmaceutical group Sanofi-Aventis published third-quarter sales figures showing a 10.7 percent increase over 12 months in line with expectations.